~~<i id='5CB91B17D1'><strike id='5CB91B17D1'><tt id='5CB91B17D1'><pre id='5CB91B17D1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：entertainment 2025-09-30 18:00:48 - browse：7759

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how tech is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

FDA approves device to save limbs of vascular disease patients

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： NIH director takes cautious approach to Biden drug pricing priority

knowledge

hotspot

leisure time

hotspot

knowledge

SuzanneKreiterGlobestaffThestate’scelebratedclusterofbiotechshashatchedbreakthroughmedicinesforevery

WSS

Prior authorization will have to move faster under new Biden rule

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Results on Novartis prostate cancer therapy could expand its use

eGenesis tests gene

FDA clears AI tool for detecting skin cancer

Merck, Daiichi strike cancer drug pact worth up to $22 billion

explore

hotspot

knowledge

Hollywood unions extend contract negotiations for actors

How digital therapeutics firms are pivoting after Pear's bankruptcy

At least 13 dead in Texas as scorching temps continue

Prior authorization will have to move faster under new Biden rule

Trump demands the U.S. pay no more for drugs than other countries … again

The tragedy of Johnson & Johnson’s Covid vaccine

State Dept. review finds Biden bears some blame for Afghanistan failures

J&J lung cancer data amount to new salvo against AstraZeneca

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

hotspot

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Independent physicians launch a new lobbying group

Study on Amgen’s bispecific immunotherapy produces positive data

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

The tragedy of Johnson & Johnson’s Covid vaccine

Readout Newsletter: Merck, J&J, and long Covid

hotspot

leisure time

hotspot

knowledge